Hussain Alizadeh

About Hussain Alizadeh

Hussain Alizadeh, With an exceptional h-index of 23 and a recent h-index of 18 (since 2020), a distinguished researcher at Pécsi Tudományegyetem, specializes in the field of General Medicine, Medical Oncology, Haematology, Clinical Pharmacology, Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Von Willebrand disease in Hungary–results of the national von Willebrand registry

Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from …

Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary

Use of blood products during the first months of COVID-19 pandemic period: A single center report

Anaemia Is Associated with an Increased Risk of Fractures, a Systematic Review, and Meta-Analysis

Clinicopathological analysis of diffuse large B-cell lymphoma using molecular biomarkers: a retrospective analysis from 7 Hungarian centers

Gaucher-kór és az ajánlott új diagnosztikai algoritmus

AML-664 A Tertiary Center's Experience With Venetoclax-Based Therapy in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Hussain Alizadeh Information

University

Position

___

Citations(all)

1512

Citations(since 2020)

1186

Cited By

643

hIndex(all)

23

hIndex(since 2020)

18

i10Index(all)

34

i10Index(since 2020)

26

Email

University Profile Page

Google Scholar

Hussain Alizadeh Skills & Research Interests

General Medicine

Medical Oncology

Haematology

Clinical Pharmacology

Immunology

Top articles of Hussain Alizadeh

Von Willebrand disease in Hungary–results of the national von Willebrand registry

Hämostaseologie

2024/2

Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from …

Pathology and Oncology Research

2024

Hussain Alizadeh
Hussain Alizadeh

H-Index: 12

Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary

Pathology and Oncology Research

2024

Hussain Alizadeh
Hussain Alizadeh

H-Index: 12

Use of blood products during the first months of COVID-19 pandemic period: A single center report

Heliyon

2023/3/1

Anaemia Is Associated with an Increased Risk of Fractures, a Systematic Review, and Meta-Analysis

2023/1/12

Clinicopathological analysis of diffuse large B-cell lymphoma using molecular biomarkers: a retrospective analysis from 7 Hungarian centers

Frontiers in Oncology

2023

Nelli Farkas
Nelli Farkas

H-Index: 18

Hussain Alizadeh
Hussain Alizadeh

H-Index: 12

Gaucher-kór és az ajánlott új diagnosztikai algoritmus

Hematológia–Transzfuziológia

2023/10/25

Hussain Alizadeh
Hussain Alizadeh

H-Index: 12

AML-664 A Tertiary Center's Experience With Venetoclax-Based Therapy in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Clinical Lymphoma Myeloma and Leukemia

2023/9/1

Ágnes Nagy
Ágnes Nagy

H-Index: 5

Hussain Alizadeh
Hussain Alizadeh

H-Index: 12

Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma

Journal of Internal Medicine

2023/9

Acquired Hemophilia A after SARS-CoV-2 Infection: A Case Report and an Updated Systematic Review

Biomedicines

2023/8/28

Ágnes Nagy
Ágnes Nagy

H-Index: 5

Hussain Alizadeh
Hussain Alizadeh

H-Index: 12

P1245: PARALLEL TESTING OF LIQUID BIOPSY (CTDNA) AND TISSUE BIOPSY SAMPLES REVEALS A HIGHER FREQUENCY OF TARGETABLE EZH2 MUTATIONS IN FOLLICULAR LYMPHOMA

HemaSphere

2023/8/1

Diagnostic and prognostic value of PACAP in multiple myeloma

International Journal of Molecular Sciences

2023/6/28

Hussain Alizadeh
Hussain Alizadeh

H-Index: 12

A diffúz nagy B-sejtes limfóma fenotipikus, citogenetikai és expressziós profil heterogenitása–Magyarországi multicentrikus tanulmány

Hematológia–Transzfuziológia

2023/4/4

Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax

International Journal of Molecular Sciences

2023/3/18

Intravenous ferric carboxymaltose versus oral ferrous sulfate replacement in elderly patients after acute non-variceal gastrointestinal bleeding (FIERCE): protocol of a …

BMJ open

2023/3/1

Az akut mieloid leukémia kezelésének új lehetőségei: út a személyre szabott terápiás stratégiák felé

Hematológia–Transzfuziológia

2022/12/21

Hussain Alizadeh
Hussain Alizadeh

H-Index: 12

Automated data preparation for in vivo tumor characterization with machine learning

Frontiers in Oncology

2022/10/11

Hussain Alizadeh
Hussain Alizadeh

H-Index: 12

Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients—Real-World Data From Hungary

Pathology & Oncology Research

2022/10/3

Hussain Alizadeh
Hussain Alizadeh

H-Index: 12

Adjuvant chemotherapy could improve the survival of pulmonary sarcomatoid carcinoma: A systematic review and meta-analysis

2022/9/1

Eduard Oštarijaš
Eduard Oštarijaš

H-Index: 1

Hussain Alizadeh
Hussain Alizadeh

H-Index: 12

90Y-ibritumomab Tiuxetan in B-cell Non-Hodgkin Lymphomas: Real-world Data From the United Arab Emirates

Advances in Radiation Oncology

2022/9/1

Nelli Farkas
Nelli Farkas

H-Index: 18

Hussain Alizadeh
Hussain Alizadeh

H-Index: 12

See List of Professors in Hussain Alizadeh University(Pécsi Tudományegyetem)

Co-Authors

academic-engine